Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea
· Delayed Price · Currency is KRW 3,165.00
-95.00 (-2.91%)
At close: Apr 28, 2026
Vivozon Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3,138 | 6,525 | 7,987 | 2,351 | 13,799 | Upgrade
|
| Short-Term Investments | 2,020 | 2,211 | 5,330 | 11,600 | 14,880 | Upgrade
|
| Trading Asset Securities | - | 1,252 | 4,404 | 12,448 | 35,376 | Upgrade
|
| Cash & Short-Term Investments | 5,158 | 9,988 | 17,721 | 26,400 | 64,055 | Upgrade
|
| Cash Growth | -48.36% | -43.64% | -32.88% | -58.79% | -29.36% | Upgrade
|
| Accounts Receivable | 9,739 | 11,900 | - | 8,847 | 10,712 | Upgrade
|
| Other Receivables | 355.87 | 368.04 | - | 347.19 | 2,428 | Upgrade
|
| Receivables | 10,223 | 14,409 | - | 9,694 | 13,163 | Upgrade
|
| Inventory | 15,849 | 19,637 | 12,994 | 11,199 | 16,034 | Upgrade
|
| Prepaid Expenses | 826.97 | 269.57 | - | 20.8 | 421.39 | Upgrade
|
| Other Current Assets | 1,482 | 103.33 | 14,423 | 248.44 | 2,659 | Upgrade
|
| Total Current Assets | 33,539 | 44,407 | 45,138 | 47,562 | 96,333 | Upgrade
|
| Property, Plant & Equipment | 26,272 | 31,814 | 25,521 | 33,968 | 32,807 | Upgrade
|
| Long-Term Investments | 86,284 | 94,560 | 91,484 | 95,242 | 45,857 | Upgrade
|
| Other Intangible Assets | 3,686 | 4,190 | 4,631 | 5,574 | 8,612 | Upgrade
|
| Long-Term Accounts Receivable | 0 | -0 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 3,431 | Upgrade
|
| Long-Term Deferred Charges | 14,716 | 7,864 | 6,209 | 3,437 | 2,880 | Upgrade
|
| Other Long-Term Assets | 984.37 | 1,614 | 662.93 | 1,006 | 653.97 | Upgrade
|
| Total Assets | 165,481 | 184,449 | 173,647 | 187,074 | 194,471 | Upgrade
|
| Accounts Payable | 7,765 | 11,827 | 10,632 | 6,152 | 6,622 | Upgrade
|
| Accrued Expenses | 1,564 | 1,575 | 1,532 | 1,848 | 2,167 | Upgrade
|
| Short-Term Debt | 40,929 | 34,476 | 39,996 | 52,572 | 67,993 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 5,604 | 867.11 | Upgrade
|
| Current Portion of Leases | 878.7 | 1,182 | 624.62 | 653.17 | 610.93 | Upgrade
|
| Current Income Taxes Payable | - | 30.1 | - | - | - | Upgrade
|
| Current Unearned Revenue | 1,851 | 1,906 | 3,504 | 3,685 | 3,685 | Upgrade
|
| Other Current Liabilities | 24,724 | 21,215 | 8,490 | 8,746 | 7,078 | Upgrade
|
| Total Current Liabilities | 77,712 | 72,211 | 64,779 | 79,261 | 89,023 | Upgrade
|
| Long-Term Debt | - | - | - | - | 13,958 | Upgrade
|
| Long-Term Leases | 533.97 | 841.95 | 994.18 | 1,481 | 685.36 | Upgrade
|
| Pension & Post-Retirement Benefits | 4,060 | 3,807 | 2,600 | 1,809 | 2,288 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 972.12 | 923.51 | 923.51 | 927.93 | 1,823 | Upgrade
|
| Other Long-Term Liabilities | 9,538 | 238.67 | 283.74 | 130.07 | 150.4 | Upgrade
|
| Total Liabilities | 92,816 | 78,022 | 69,580 | 83,609 | 107,928 | Upgrade
|
| Common Stock | 125,262 | 125,262 | 120,529 | 117,022 | 84,953 | Upgrade
|
| Additional Paid-In Capital | 250,604 | 249,419 | 245,296 | 243,684 | 216,611 | Upgrade
|
| Retained Earnings | -303,792 | -271,829 | -261,313 | -257,365 | -216,914 | Upgrade
|
| Treasury Stock | -10.05 | -13.12 | -18.19 | - | - | Upgrade
|
| Comprehensive Income & Other | 601.24 | 3,588 | -427.4 | 125.39 | 469.82 | Upgrade
|
| Total Common Equity | 72,665 | 106,427 | 104,067 | 103,466 | 85,120 | Upgrade
|
| Minority Interest | - | - | - | - | 1,422 | Upgrade
|
| Shareholders' Equity | 72,665 | 106,427 | 104,067 | 103,466 | 86,542 | Upgrade
|
| Total Liabilities & Equity | 165,481 | 184,449 | 173,647 | 187,074 | 194,471 | Upgrade
|
| Total Debt | 42,341 | 36,500 | 41,615 | 60,310 | 84,115 | Upgrade
|
| Net Cash (Debt) | -37,183 | -26,512 | -23,894 | -33,910 | -20,060 | Upgrade
|
| Net Cash Per Share | -751.13 | -555.09 | -500.74 | -779.45 | -615.13 | Upgrade
|
| Filing Date Shares Outstanding | 49.51 | 49.38 | 47.21 | 46.81 | 33.98 | Upgrade
|
| Total Common Shares Outstanding | 49.51 | 49.38 | 47.21 | 46.81 | 33.98 | Upgrade
|
| Working Capital | -44,173 | -27,804 | -19,640 | -31,699 | 7,310 | Upgrade
|
| Book Value Per Share | 1467.54 | 2155.28 | 2204.51 | 2210.40 | 2504.91 | Upgrade
|
| Tangible Book Value | 68,979 | 102,237 | 99,436 | 97,892 | 76,508 | Upgrade
|
| Tangible Book Value Per Share | 1393.10 | 2070.44 | 2106.41 | 2091.33 | 2251.47 | Upgrade
|
| Land | 6,037 | 6,037 | 6,037 | 6,037 | 6,183 | Upgrade
|
| Buildings | 10,694 | 6,835 | 6,678 | 6,557 | 7,886 | Upgrade
|
| Machinery | 23,766 | 23,153 | 23,401 | 20,015 | 22,216 | Upgrade
|
| Construction In Progress | 47.23 | 7,598 | 1,943 | 12,132 | 9,142 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.